CREATE Medicines News and Activities

Acquisition, funding and merger involving CREATE Medicines.

• CREATE Medicines has just announced a $122 Million fundraising (posted on May 15 2026).
• The new name of Myeloid Therapeutics is CREATE Medicines. (posted on October 10 2025).

View the org chart displaying its 19 main executives

Most searched biographies at CREATE Medicines

• Daniel Getts, Chief Executive Officer and Director
• Brett Kaplan, Director
• Stanley Frankel, Director

Popular executive movements at CREATE Medicines

• Allan Shaw has joined the company as Chief Financial Officer and Chief Business Officer  (posted on October 10 2025).

Create your alert
to follow the executive moves at CREATE Medicines.

CREATE Medicines has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by CREATE Medicines

• News Archives - Myeloid Therapeutics
• News & Events - Myeloid Therapeutics

Social media about CREATE Medicines

• CREATE Medicines on Wikipedia, Google News & Yahoo Finance
• CREATE Medicines on LinkedIn, X (Twitter) & YouTube